| scholarly article | Q13442814 |
| P2093 | author name string | A J Marcus | |
| H L Ullman | |||
| L B Safier | |||
| M J Broekman | |||
| N Islam | |||
| J Aznar | |||
| J Valles | |||
| M T Santos | |||
| A M Eiroa | |||
| P2860 | cites work | Platelet-neutrophil interactions. 12S,20- and 5S,12S-dihydroxyeicosapentaenoic acids: two novel neutrophil metabolites from platelet-derived 12S-hydroxyeicosapentaenoic acid | Q68347288 |
| Role of red blood cells in the early stages of platelet activation by collagen | Q68976759 | ||
| Calcium-dependent proteolysis occurs during platelet aggregation | Q70158655 | ||
| Uptake, release and metabolism of docosahexaenoic acid (DHA, c22:6 omega 3) in human platelets and neutrophils | Q70217000 | ||
| Preferential utilization of endogenous arachidonate by cyclo-oxygenase in incubations of human platelets | Q70437237 | ||
| Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms | Q70668394 | ||
| The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness | Q78876195 | ||
| Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties | Q27863422 | ||
| The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin | Q28361275 | ||
| Studies on human platelet granules and membranes | Q34080107 | ||
| Biochemical mechanisms of platelet activation | Q38677892 | ||
| Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy | Q39159259 | ||
| Synergistic activation by collagen and 15-hydroxy-9 alpha,11 alpha-peroxidoprosta-5,13-dienoic acid (PGH2) of phosphatidylinositol metabolism and arachidonic acid release in human platelets | Q40681826 | ||
| Inhibition of protein cross-linking in Ca2+-enriched human erythrocytes and activated platelets | Q42161366 | ||
| Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid | Q42205760 | ||
| Dihomogammalinolenic acid, but not eicosapentaenoic acid, activates washed human platelets | Q42240393 | ||
| Transformations of 5,8,11,14,17-eicosapentaenoic acid in human platelets | Q42244685 | ||
| Serine esterase inhibitors block stimulus-induced mobilization of arachidonic acid and phosphatidylinositide-specific phospholipase C activity in platelets. | Q42272308 | ||
| Mobilization of arachidonic acid in collagen-stimulated human platelets | Q42820966 | ||
| Eicosanoid interactions between platelets, endothelial cells, and neutrophils | Q43670324 | ||
| Early platelet-collagen interactions in whole blood and their modifications by aspirin and dipyridamole evaluated by a new method (BASIC wave). | Q54373371 | ||
| Cardiovascular Effects of n-3 Fatty Acids | Q56673207 | ||
| Accumulation of 1,2-diacylglycerol in the plasma membrane may lead to echinocyte transformation of erythrocytes | Q59076629 | ||
| Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis | Q59096154 | ||
| Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation | Q67339154 | ||
| Mechanism for irreversible self-deactivation of prostaglandin synthetase | Q67530277 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 571-580 | |
| P577 | publication date | 1991-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment | |
| P478 | volume | 87 |
| Q91845167 | A Novel Rapid Method of Red Blood Cell and Platelet Permeabilization and Staining for Flow Cytometry Analysis |
| Q28213348 | A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes |
| Q43700338 | Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss |
| Q40014803 | Antiplatelet Resistance-Does it Exist and How to Measure it? |
| Q73447635 | Antiplatelet effects of sodium nitroprusside in flowing human blood: studies under normoxic and hypoxic conditions |
| Q28213984 | Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods |
| Q77676648 | Aspirin analogs as antithrombotic agents |
| Q28217948 | Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease |
| Q33381155 | Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion |
| Q28194204 | Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy |
| Q35856151 | Current status of transfusion triggers for red blood cell concentrates |
| Q38046968 | Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats. |
| Q33902134 | Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins |
| Q28222480 | Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease |
| Q40115273 | Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood |
| Q46549946 | Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro |
| Q42504487 | Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on agonist-induced platelet aggregation and RANTES release in vitro. |
| Q38934014 | Elevated hematocrit enhances platelet accumulation following vascular injury. |
| Q34585744 | Eryptosis as a marker of Parkinson's disease |
| Q33419140 | Erythrocyte-platelet interaction in uncomplicated pregnancy |
| Q35009741 | Greater collagen-induced platelet aggregation following cyclooxygenase 1 inhibition predicts incident acute coronary syndromes |
| Q33632252 | Hematocrit and risk of venous thromboembolism in a general population. The Tromso study |
| Q34305696 | Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study |
| Q30491404 | Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury |
| Q42922568 | High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? |
| Q46005790 | Homocysteine induces procoagulant activity of red blood cells via phosphatidylserine exposure and microparticles generation. |
| Q46769575 | Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer. |
| Q79290699 | Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test |
| Q42479093 | Influence of treatment with ultralow-dose aspirin on platelet aggregation as measured by whole blood impedance aggregometry and platelet P-selectin expression in clinically normal dogs |
| Q83968093 | Massive transfusion and coagulopathy: pathophysiology and implications for clinical management |
| Q33678363 | Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation. |
| Q35181680 | Nitric oxide and its relationship to thrombotic disorders |
| Q77907974 | Nitric oxide and superoxide detection in human platelets |
| Q37369997 | Nitric oxide released from activated platelets inhibits platelet recruitment |
| Q28218548 | PGE(2) in the regulation of programmed erythrocyte death |
| Q64230387 | Platelet and Red Blood Cell Counts, as well as the Concentrations of Uric Acid, but Not Homocysteinaemia or Oxidative Stress, Contribute Mostly to Platelet Reactivity in Older Adults |
| Q28221566 | Platelet function testing: state of the art |
| Q35976574 | Platelet isoprostane overproduction in diabetic patients treated with aspirin |
| Q43280508 | Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer. |
| Q33437331 | Platelets in liver and renal disease |
| Q28192943 | Possible mechanisms of aspirin resistance |
| Q46789003 | Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. |
| Q28186905 | Profile and prevalence of aspirin resistance in patients with cardiovascular disease |
| Q31044507 | Purification and characterization of a cytosolic, 42-kDa and Ca2+-dependent phospholipase A2 from bovine red blood cells: its involvement in Ca2+-dependent release of arachidonic acid from mammalian red blood cells |
| Q48003288 | Red blood cells in thrombosis. |
| Q46790430 | Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease |
| Q48123631 | Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test. |
| Q28212522 | Stimulation of suicidal erythrocyte death by lipoxygenase inhibitor Bay-Y5884 |
| Q43255962 | Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate |
| Q33909935 | Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen |
| Q28200575 | The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events |
| Q28189964 | The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation |
| Q51038302 | The time between venepuncture and blood incubation is critical for serum thromboxane B2 synthesis. |
| Q35597837 | Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions |
| Q40448208 | Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. |
| Q79345654 | [Prerequisites of a functional haemostasis. What must be considered at the scene of an accident, in the emergency room and during an operation?] |
Search more.